Opioid Addiction Treatment in Lexington, Kentucky
Kentucky has been at the epicenter of the national opioid crisis since its earliest stages, and Lexington — as the state's second-largest city and Fayette County's population center — has experienced the full trajectory of that crisis. Prescription opioid misuse transitioned to heroin use, which then gave way to illicitly manufactured fentanyl that now dominates the overdose death toll. Kentucky recorded 1,410 overdose deaths in 2024 according to the Kentucky Office of Drug Control Policy, with opioids involved in the vast majority. Inpatient opioid treatment in Lexington combines medically supervised detox, medication-assisted treatment, and behavioral therapy to address the neurological, physical, and psychological dimensions of opioid use disorder.
What medications are used to treat opioid addiction?
Three FDA-approved medications are the cornerstone of opioid addiction treatment: buprenorphine, methadone, and naltrexone. Buprenorphine (marketed as Suboxone, Subutex, and Sublocade) is a partial opioid agonist that reduces cravings and withdrawal symptoms while having a ceiling effect that limits overdose risk. Methadone is a full opioid agonist dispensed through certified programs that provides stable relief from withdrawal and cravings. Naltrexone (Vivitrol) is an opioid antagonist that blocks the effects of opioids entirely — it requires complete detoxification before initiation but is available as a monthly injection that removes daily adherence decisions. Research published in the New England Journal of Medicine demonstrates that medication-assisted treatment reduces opioid-related mortality by approximately 50% and increases treatment retention rates significantly. Lexington-area inpatient programs that integrate MAT with behavioral therapy deliver the strongest clinical outcomes.
What is the success rate of opioid recovery?
Opioid recovery success rates depend heavily on the treatment approach and how success is measured. With medication-assisted treatment, one-year retention rates range from 40% to 60%, and opioid-related mortality drops by approximately 50%. Without MAT, relapse rates for opioid use disorder exceed 80% within the first year. The clinical consensus is that opioid use disorder is a chronic condition requiring long-term management — similar to diabetes or hypertension — rather than a condition that is cured in a single treatment episode. Individuals who complete 90 or more days of inpatient treatment, continue MAT after discharge, and participate in ongoing outpatient therapy and peer support show the highest rates of sustained recovery. Kentucky's investment in expanding MAT access across the state reflects the evidence that medication is not optional but essential in opioid treatment.
What is the timeline for opioid withdrawal?
The opioid withdrawal timeline depends on the specific opioid. Short-acting opioids like heroin and immediate-release oxycodone produce withdrawal symptoms within 8 to 12 hours, peaking at 36 to 72 hours and resolving within 5 to 7 days. Long-acting opioids like methadone or extended-release formulations may not produce withdrawal symptoms until 24 to 48 hours after the last dose, with peak symptoms at 72 to 96 hours and resolution over 10 to 14 days. Fentanyl withdrawal follows a pattern similar to short-acting opioids but can be more intense due to fentanyl's high potency. Post-acute withdrawal syndrome (PAWS) — characterized by persistent anxiety, depression, insomnia, and cravings — can continue for weeks to months after acute withdrawal resolves. Medically supervised detox manages all phases of this timeline with appropriate medications.
What happens after opioid detox?
Completing detox is the beginning of treatment, not the end. After the acute withdrawal phase, patients transition into the residential treatment component of inpatient care, where they engage in individual therapy, group therapy, MAT initiation or continuation, and relapse prevention planning. This phase typically lasts 21 to 83 additional days depending on the program length. The transition from detox to therapeutic engagement is where the psychological and behavioral work of recovery begins.
What is the 72 hour rule for opioids?
The 72-hour rule refers to the federal regulation that allows physicians to administer (but not prescribe) opioid agonist medications like buprenorphine or methadone for up to 72 hours to manage acute withdrawal symptoms while arranging for ongoing treatment. This rule applies specifically to emergency and inpatient settings where a patient presents in opioid withdrawal and needs immediate stabilization. In practice, this means that a Lexington emergency department or inpatient facility can begin buprenorphine administration to manage withdrawal symptoms for up to three days, during which time the patient can be connected with an inpatient rehab program that continues MAT as part of a comprehensive treatment plan. This rule bridges the gap between crisis presentation and formal treatment admission.
What are the worst days of opioid withdrawal?
Days 2 and 3 after the last opioid dose are typically the worst for short-acting opioids like heroin and fentanyl. During this peak withdrawal window, individuals experience the most intense combination of physical symptoms — severe muscle and bone pain, nausea, vomiting, diarrhea, cold sweats, and goosebumps — along with extreme psychological distress including anxiety, agitation, and insomnia. For long-acting opioids, the worst days are typically days 3 to 5. This peak period is when the risk of returning to use is highest, which is precisely why medically supervised detox in an inpatient setting is the recommended standard of care. Clinical staff monitor symptoms around the clock, administer medications that reduce symptom intensity, and provide the supervised environment that prevents access to opioids during the most vulnerable phase of recovery.
Ready to Start Treatment?
Our placement specialists verify your PPO insurance in 15 minutes and walk you through every option — no pressure, no obligation.
Frequently Asked Questions
What medications are used to treat opioid addiction?
Three FDA-approved medications treat opioid addiction: buprenorphine (Suboxone/Sublocade), methadone, and naltrexone (Vivitrol). Buprenorphine reduces cravings as a partial agonist, methadone provides stable full-agonist relief, and naltrexone blocks opioid effects entirely. MAT reduces opioid mortality by approximately 50% and is considered essential — not optional — in evidence-based treatment.
What is the success rate of opioid recovery?
With medication-assisted treatment, one-year retention rates are 40-60% and mortality drops by approximately 50%. Without MAT, relapse rates exceed 80% in the first year. Opioid use disorder is managed as a chronic condition — individuals who stay on MAT, complete 90+ days of treatment, and continue aftercare show the highest sustained recovery rates.
What is the timeline for opioid withdrawal?
Short-acting opioid withdrawal begins within 8-12 hours, peaks at 36-72 hours, and resolves in 5-7 days. Long-acting opioids produce withdrawal starting at 24-48 hours, peaking at 72-96 hours. Post-acute symptoms — anxiety, insomnia, cravings — can persist for months. Medically supervised detox manages all phases safely.
What is the 72 hour rule for opioids?
The 72-hour rule allows physicians to administer buprenorphine or methadone for up to 72 hours in emergency or inpatient settings to manage acute withdrawal while arranging ongoing treatment. This bridges the gap between crisis presentation and formal rehab admission, ensuring patients receive immediate stabilization.
What are the worst days of opioid withdrawal?
Days 2-3 after the last dose are typically the worst for short-acting opioids like heroin and fentanyl, with peak physical symptoms and psychological distress. For long-acting opioids, days 3-5 are most intense. This peak period is when relapse risk is highest, making medically supervised inpatient detox the safest option.